Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects

Chronic Diseases and Translational Medicine(2020)10.1016/j.cdtm.2020.01.002Source: DataRank Database

Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects is a research paper published in Chronic Diseases and Translational Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 70 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access70 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)OA: goldTopics (12)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Jia‐Long Yuan,Diego Trafton,Jianxin Wang ORCID,Nan Niu ORCID,Chunhui Yuan ORCID

Live enrichment

PubMed:32226930 PMC:PMC7096327

National Institutes of Health

Grant: R01 CA169702

National Institutes of Health

Grant: R01 CA197296

National Cancer Institute

Grant: P50 CA062924

Sidney Kimmel Comprehensive Cancer Center

Grant: P30 CA006973

National Institutes of Health

Grant: 5P50CA062924-05

CORE--COLORECTAL AND PANCREATIC CANCER PATIENT REGISTRY

National Institutes of Health

Grant: 5R01CA169702-05

Annexin A2 as a mediator of pancreatic cancer metastases

National Institutes of Health

Grant: 5R01CA197296-05

Reprogramming the pancreatic tumor microenvironment with immunotherapy

National Institutes of Health

Grant: 3P30CA006973-53S2

Regional Oncology Research Center

National Institutes of Health

Grant: 5P50CA062924-25

SPORE in Gastrointestinal Cancers

Skip Viragh Pancreatic Cancer Center

Johns Hopkins

Johns Hopkins University

Influential Citations

goldLicense: cc-by-nc-nd

HYBRIDhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.cdtm.2020.01.002

publisherhttps://doi.org/10.1016/j.cdtm.2020.01.002

publisherhttps://api.elsevier.com/content/article/PII:S2095882X20300025?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2095882X20300025?httpAccept=text/plain

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1016/j.cdtm.2020.01.002

Fields of Study

MedicineBiology0301 basic medicine03 medical and health sciences

Keywords

ImmunotherapyCancer vaccinePancreatic Ductal AdenocarcinomaTumor MicroenvironmentStimulator Of Interferon GenesMedicine (General)R5-920Review Article

Sustainable Development Goals

SDG 3: 3. Good health

Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects

FAIR Checklist

Authors (8)

Funding (12 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)